Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Sai-Hong Ignatius Ou"'
Autor:
Sai-Hong Ignatius Ou, Jin-Liern Hong, Petros Christopoulos, Huamao M. Lin, Sylvie Vincent, Eric N. Churchill, Junpei Soeda, Daniel Kazdal, Albrecht Stenzinger, Michael Thomas
Publikováno v:
Journal of Thoracic Oncology. 18:744-754
Autor:
Natthaya Triphuridet, Shannon S. Zhang, Misako Nagasaka, Yanfei Gao, Joseph J. Zhao, Nicholas L. Syn, Takaomi Hanaoka, Sai-Hong Ignatius Ou, Elaine Shum
Publikováno v:
Journal of Thoracic Oncology. 18:698-717
Autor:
Sai-Hong Ignatius, Ou, Makoto, Nishio, Myung-Ju, Ahn, Tony, Mok, Fabrice, Barlesi, Caicun, Zhou, Enriqueta, Felip, Filippo, de Marinis, Sang-We, Kim, Maurice, Pérol, Geoffrey, Liu, Maria Rita, Migliorino, Dong-Wan, Kim, Silvia, Novello, Alessandra, Bearz, Pilar, Garrido, Julien, Mazieres, Alessandro, Morabito, Huamao M, Lin, Hui, Yang, Huifeng, Niu, Pingkuan, Zhang, Edward S, Kim
Publikováno v:
Scientia
Circulating tumor DNA; Non–small cell lung cancer; Tumor biomarker ADN tumoral circulante; Cáncer de pulmón de células no pequeñas; Biomarcador tumoral ADN tumoral circulant; Càncer de pulmó de cèl·lules no petites; Biomarcador tumoral Intr
Autor:
Sally C.M. Lau, Sai-Hong Ignatius Ou
Publikováno v:
Journal of Thoracic Oncology. 18:561-563
Autor:
Sally C M, Lau, Sai-Hong Ignatius, Ou
Publikováno v:
Journal of Thoracic Oncology. 17:1144-1154
Autor:
Lihong, Zhang, Xia, Yang, Zongjuan, Ming, Jie, Shi, Xin, Lv, Wei, Li, Bo, Yuan, Yang, Chen, Boxuan, Liu, Kai, Qin, Jiamin, Liu, Qingbo, Wei, Dejian, Gu, Rongrong, Chen, Mingming, Yuan, Jean, Cui, Sai-Hong Ignatius, Ou, Shuanying, Yang
Publikováno v:
Clinical Lung Cancer. 23:311-319
Epidermal growth factor receptor (EGFR) T854A is an uncommon exon 21 mutation in patients with non-small cell lung cancer (NSCLC). It was first reported in samples collected after first generation EGFR tyrosine kinase inhibitor (TKI) treatment as an
Publikováno v:
Journal of Thoracic Oncology. 18:e57-e58
Autor:
Sai-Hong, Ignatius Ou
Publikováno v:
Journal of Thoracic Oncology. 17:e86-e88
Autor:
Sai-Hong Ignatius Ou, Xingxiang Xu, Yuan Chen, Chuan Li, Ying Cheng, Ziping Wang, Changan Sun, Kai Wang, Jianhua Chen, Qiong Wu, Zhehai Wang, R. Guo, Te Chun Hsia, Zhuang Yu, Jian Fang, Shaoshui Chen, Haihua Yang, Yong Song, Chin-Chou Wang, Xiaorong Dong, Jianxing He, Her-Shyong Shiah, Ping Wang, Cheng-Ta Yang, Hongying Wei, Yuping Sun, Viola W. Zhu, Jianhua Shi, Guojun Zhang, Wu Chou Su, Jifeng Feng, Jianying Zhou, Jiuwei Cui, Nong Yang, Shun Lu, Yanping Hu, Qiming Wang, Hongming Pan, Chao-Hua Chiu, Gee-Chen Chang, You Lu, James Chih-Hsin Yang
Publikováno v:
Journal of Thoracic Oncology. 17:411-422
Aumolertinib (formerly almonertinib; HS-10296) is a novel third-generation EGFR tyrosine kinase inhibitor (TKI) with revealed activity against EGFR-sensitizing mutations and EGFR T790M mutation.Patients with locally advanced or metastatic NSCLC who d
Publikováno v:
Journal of Thoracic Oncology. 17:182-185